» Articles » PMID: 29502307

Role of the Nervous System in Tumor Angiogenesis

Overview
Publisher Springer
Specialty Oncology
Date 2018 Mar 5
PMID 29502307
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

The development of cancer involves an intricate process, wherein many identified and unidentified factors play a role. Tumor angiogenesis, growth of new blood vessels, is one of the major prerequisites for tumor growth as tumor cells rely on adequate oxygen and nutrient supply as well as the removal of waste products. Growth factors including VEGF orchestrate the development of angiogenesis. In addition, nervous system via the release of neurotransmitters contributes to tumor angiogenesis. The nervous system governs functional activities of many organs, and, as tumors are not independent organs within an organism, this system is integrally involved in tumor growth and progression via regulating tumor angiogenesis. Various neurotransmitters have been reported to play an important role in tumor angiogenesis.

Citing Articles

Hijacking of the nervous system in cancer: mechanism and therapeutic targets.

Zhang Y, Liao Q, Wen X, Fan J, Yuan T, Tong X Mol Cancer. 2025; 24(1):44.

PMID: 39915765 PMC: 11800603. DOI: 10.1186/s12943-025-02246-5.


Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer.

Liu S, Zhang X, Wang W, Li X, Sun X, Zhao Y Mol Cancer. 2024; 23(1):261.

PMID: 39574178 PMC: 11580516. DOI: 10.1186/s12943-024-02165-x.


Recent updates on potential of VEGFR-2 small-molecule inhibitors as anticancer agents.

Chaudhari P, Nemade A, Shirkhedkar A RSC Adv. 2024; 14(45):33384-33417.

PMID: 39439843 PMC: 11495155. DOI: 10.1039/d4ra05244g.


Nerve Growth Factor and the Role of Inflammation in Tumor Development.

Ferraguti G, Terracina S, Tarani L, Fanfarillo F, Allushi S, Caronti B Curr Issues Mol Biol. 2024; 46(2):965-989.

PMID: 38392180 PMC: 10888178. DOI: 10.3390/cimb46020062.


PICALM as a Novel Prognostic Biomarker and Its Correlation with Immune Infiltration in Breast Cancer.

A N, Lyu P, Yu Y, Liu M, Cheng S, Chen M Appl Biochem Biotechnol. 2024; 196(9):6011-6027.

PMID: 38175412 DOI: 10.1007/s12010-023-04840-z.


References
1.
Wang W, Zhao Z, Ma S, Yu G, Liu B, Zhang L . Epidermal growth factor receptor inhibition reduces angiogenesis via hypoxia-inducible factor-1α and Notch1 in head neck squamous cell carcinoma. PLoS One. 2015; 10(2):e0119723. PMC: 4344331. DOI: 10.1371/journal.pone.0119723. View

2.
Quail D, Joyce J . Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013; 19(11):1423-37. PMC: 3954707. DOI: 10.1038/nm.3394. View

3.
Staniszewska I, Sariyer I, Lecht S, Brown M, Walsh E, Tuszynski G . Integrin alpha9 beta1 is a receptor for nerve growth factor and other neurotrophins. J Cell Sci. 2008; 121(Pt 4):504-13. PMC: 2744358. DOI: 10.1242/jcs.000232. View

4.
Miyake M, Goodison S, Lawton A, Gomes-Giacoia E, Rosser C . Angiogenin promotes tumoral growth and angiogenesis by regulating matrix metallopeptidase-2 expression via the ERK1/2 pathway. Oncogene. 2014; 34(7):890-901. PMC: 4317372. DOI: 10.1038/onc.2014.2. View

5.
Katona T, Neubauer B, Iversen P, Zhang S, Baldridge L, Cheng L . Elevated expression of angiogenin in prostate cancer and its precursors. Clin Cancer Res. 2005; 11(23):8358-63. DOI: 10.1158/1078-0432.CCR-05-0962. View